GPI
PFE icon

General Partner Inc’s Pfizer PFE Stock Holding History

General Partner Inc’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-158
Closed -$4.57K – 175
2024
Q3 		$4.57K Hold
158
– – ﹤0.01% 155
2024
Q2 		$4.42K Hold
158
– – ﹤0.01% 158
2024
Q1 		$4.38K Sell
158
-2,210
-93% -$61.3K ﹤0.01% 165
2023
Q4 		$68.2K Hold
2,368
– – 0.06% 89
2023
Q3 		$78.5K Hold
2,368
– – 0.07% 89
2023
Q2 		$86.9K Hold
2,368
– – 0.07% 88
2023
Q1 		$96.7K Buy
2,368
+158
+7% +$6.82K 0.09% 83
2022
Q4 		$113K Buy
+2,210
New +$106K 0.1% 76

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

General Partner Inc's PFE Position: Q4 2024 in Review

General Partner Inc sold out of Pfizer (PFE) in Q4 2024, closing a stake of 158 shares — an estimated $4.57K sold.

General Partner Inc first reported a position in PFE in Q4 2022 and held it in 8 quarters. The position peaked at $113K in Q4 2022. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • General Partner Inc reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • General Partner Inc sold 158 Pfizer shares in Q4 2024, an estimated $4.57K.
  • General Partner Inc first reported a position in Pfizer in Q4 2022 and held it in 8 quarters.
  • General Partner Inc's Pfizer position peaked at $113K in Q4 2022.
  • 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on General Partner Inc's 13F filing for Q4 2024, filed 3 Jan 2025.